Status:
COMPLETED
Trial to Evaluate the Ability of a Single Infusion of High-Density Lipoprotein (HDL) to Modulate Markers of Cerebral Ischaemia
Lead Sponsor:
St George's, University of London
Conditions:
Stroke
Eligibility:
All Genders
Phase:
NA
Brief Summary
The plasma concentration of high-density lipoprotein (HDL) can have anti-inflammatory, anti-oxidative and anti-thrombotic effects in addition to being able to remove cholesterol from peripheral tissue...
Detailed Description
Following written informed consent, patients will be randomised to either the placebo or active arm of the study. Bloods will be taken for baseline measurements, and the infusion of either saline (pla...
Eligibility Criteria
Inclusion
- patients listed for elective carotid endarterectomy
Exclusion
- pregnant women and women of childbearing age
- patient with impaired renal function or liver function
- patients sectioned under the Mental Health Act
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00822302
Start Date
February 1 2006
End Date
February 1 2009
Last Update
June 9 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St Georges University of London
London, Tooting, United Kingdom, SW17 0QT